
pmid: 25034156
Systemic lupus erythematosus (SLE) is an autoimmune disease that is characterized by the development of autoantibodies and immunologic attack of different organ systems, including the skin. This review aims to provide an overview of some of the pathogenic processes that may be important in the development of SLE, specifically cutaneous lupus erythematosus, and then illustrates how therapies might be tailored to modify these processes and treat disease.
Immunomodulation, Risk Factors, Ultraviolet Rays, Disease Progression, Lupus Erythematosus, Cutaneous, Humans, Interferon-alpha, Lupus Erythematosus, Systemic, Autoimmunity, Immunity, Innate
Immunomodulation, Risk Factors, Ultraviolet Rays, Disease Progression, Lupus Erythematosus, Cutaneous, Humans, Interferon-alpha, Lupus Erythematosus, Systemic, Autoimmunity, Immunity, Innate
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 29 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
